| Primary |
| Metastatic Renal Cell Carcinoma |
26.0% |
| Renal Cell Carcinoma |
22.7% |
| Renal Cancer |
12.4% |
| Gastrointestinal Stromal Tumour |
7.9% |
| Renal Cell Carcinoma Stage Unspecified |
7.0% |
| Hypertension |
6.1% |
| Renal Cancer Metastatic |
3.8% |
| Pain |
3.1% |
| Diabetes Mellitus |
1.7% |
| Neoplasm Malignant |
1.4% |
| Nausea |
1.1% |
| Prostate Cancer |
0.9% |
| Thyroid Cancer |
0.9% |
| Gastrooesophageal Reflux Disease |
0.8% |
| Constipation |
0.8% |
| Depression |
0.7% |
| Blood Pressure |
0.7% |
| Hypothyroidism |
0.7% |
| Blood Cholesterol Increased |
0.6% |
| Pancreatic Neuroendocrine Tumour |
0.6% |
|
| Death |
37.8% |
| Vomiting |
7.1% |
| Thrombocytopenia |
5.6% |
| Renal Cell Carcinoma |
4.3% |
| Disease Progression |
4.1% |
| Renal Cancer |
3.8% |
| Weight Decreased |
3.7% |
| White Blood Cell Count Decreased |
3.7% |
| Yellow Skin |
3.1% |
| Palmar-plantar Erythrodysaesthesia Syndrome |
2.7% |
| Toxicity To Various Agents |
2.7% |
| Stomatitis |
2.7% |
| Platelet Count Decreased |
2.6% |
| Drug Toxicity |
2.5% |
| Diarrhoea |
2.4% |
| Pleural Effusion |
2.2% |
| Pyrexia |
2.2% |
| Fatigue |
2.2% |
| Hypertension |
2.2% |
| Renal Failure |
2.2% |
|
| Secondary |
| Metastatic Renal Cell Carcinoma |
18.1% |
| Renal Cell Carcinoma |
17.3% |
| Hypertension |
10.3% |
| Renal Cancer |
9.4% |
| Pain |
6.6% |
| Gastrointestinal Stromal Tumour |
5.5% |
| Product Used For Unknown Indication |
5.2% |
| Drug Use For Unknown Indication |
3.8% |
| Renal Cancer Metastatic |
3.5% |
| Diabetes Mellitus |
3.1% |
| Metastases To Lung |
2.1% |
| Prostate Cancer |
1.9% |
| Metastases To Bone |
1.8% |
| Blood Pressure |
1.8% |
| Pancreatic Carcinoma |
1.7% |
| Constipation |
1.7% |
| Gastrooesophageal Reflux Disease |
1.7% |
| Hypothyroidism |
1.6% |
| Depression |
1.5% |
| Nausea |
1.3% |
|
| Weight Decreased |
13.0% |
| Vomiting |
9.4% |
| White Blood Cell Count Decreased |
7.7% |
| Yellow Skin |
7.5% |
| Stomatitis |
5.8% |
| Thrombocytopenia |
5.7% |
| Death |
5.6% |
| Palmar-plantar Erythrodysaesthesia Syndrome |
5.0% |
| Renal Cell Carcinoma |
4.6% |
| Weight Increased |
4.1% |
| Diarrhoea |
4.0% |
| Disease Progression |
3.6% |
| Fatigue |
3.3% |
| Nausea |
3.2% |
| Rash |
3.1% |
| Urinary Tract Infection |
3.1% |
| Hypertension |
3.0% |
| Platelet Count Decreased |
2.9% |
| Dysgeusia |
2.8% |
| Skin Exfoliation |
2.7% |
|
| Concomitant |
| Metastatic Renal Cell Carcinoma |
14.6% |
| Renal Cell Carcinoma |
12.8% |
| Metastases To Bone |
9.7% |
| Renal Cancer |
8.5% |
| Drug Use For Unknown Indication |
7.0% |
| Pain |
6.1% |
| Hypertension |
4.3% |
| Product Used For Unknown Indication |
4.3% |
| Cancer Pain |
3.8% |
| Gastrointestinal Stromal Tumour |
3.5% |
| Prophylaxis |
3.2% |
| Renal Cancer Metastatic |
3.1% |
| Renal Cell Carcinoma Stage Iv |
2.8% |
| Chest Pain |
2.7% |
| Diabetes Mellitus |
2.4% |
| Renal Cell Carcinoma Stage Unspecified |
2.4% |
| Anxiety |
2.3% |
| Carcinoid Syndrome |
2.2% |
| Neoplasm Malignant |
2.2% |
| Gastritis |
1.9% |
|
| Osteonecrosis |
14.1% |
| Osteonecrosis Of Jaw |
10.6% |
| Wound Dehiscence |
10.1% |
| Death |
8.1% |
| Vomiting |
5.1% |
| White Blood Cell Count Decreased |
5.1% |
| Renal Cell Carcinoma |
4.5% |
| Weight Decreased |
4.5% |
| Neoplasm Malignant |
3.5% |
| Toothache |
3.5% |
| Vision Blurred |
3.5% |
| Drug Ineffective |
3.0% |
| Hypertension |
3.0% |
| Pain |
3.0% |
| Pancreatic Enzymes Increased |
3.0% |
| Rash |
3.0% |
| Splenic Lesion |
3.0% |
| Tooth Disorder |
3.0% |
| Tooth Extraction |
3.0% |
| Weight Increased |
3.0% |
|
| Interacting |
| Metastases To Lung |
9.5% |
| Renal Cancer Metastatic |
9.5% |
| Thrombosis Prophylaxis |
8.1% |
| Hypertension |
6.8% |
| Bone Disorder |
5.4% |
| Renal Cancer |
5.4% |
| Anxiety |
4.1% |
| Atrial Fibrillation |
4.1% |
| Blood Glucose Abnormal |
4.1% |
| Blood Pressure Increased |
4.1% |
| Colitis Ulcerative |
4.1% |
| Convulsion |
4.1% |
| Hypercholesterolaemia |
4.1% |
| Insomnia |
4.1% |
| Metastases To Bone |
4.1% |
| Metastases To Central Nervous System |
4.1% |
| Metastases To Pleura |
4.1% |
| Mycosis Fungoides |
4.1% |
| Thymoma Malignant |
4.1% |
| Blood Pressure |
2.7% |
|
| Drug Interaction |
18.5% |
| White Blood Cell Count Increased |
14.8% |
| Vision Blurred |
11.1% |
| Haemoptysis |
7.4% |
| Hypothyroidism |
7.4% |
| Osteonecrosis Of Jaw |
7.4% |
| Ventricular Tachycardia |
7.4% |
| International Normalised Ratio Increased |
3.7% |
| Left Ventricular Failure |
3.7% |
| Pain |
3.7% |
| Palmar-plantar Erythrodysaesthesia Syndrome |
3.7% |
| Skin Lesion |
3.7% |
| Thrombocytopenia |
3.7% |
| Toxicity To Various Agents |
3.7% |
|
